Conclusion:
A greater amount of DRPs were detected and more therapeutic advice was
proposed during the first wave of COVID-19, with a focus on drugs used
for the management of COVID-19 rather than geriatric routine treatments.
The needs for clinical pharmacists were strengthened during the
pandemic.